GLP-1 drugs like Ozempic and Wegovy may reduce cancer risk by up to 58%, outperforming diet and exercise alone
Medicare's new GLP-1 Bridge program offers eligible beneficiaries Wegovy, Zepbound, or Foundayo for $50 a month starting July 1, 2026.
The Dutch Army is testing a prisoner-of-war camp design for the first time in 30 years
New research links regular fish oil use to a 13% higher AFib risk and 5% higher stroke risk in healthy adults. Here's what the science really
New research finally explains statin muscle pain at the molecular level. Learn what happens in your muscles, how serious it can get
Trump poll results in June 2026 show 35% approval, record disapproval on the economy, and a collapsing generic ballot
Several congressional bills aim to deliver a social security benefits increase to millions of Americans
Trump's $10B IRS lawsuit ended in a $1.776B settlement fund in 2026. Here's what the trump billions fight means for presidential ethics and
A secret Situation Room meeting, a Tucker Carlson prison interview pitch, and a leak hunt: inside the White House's escalating crisis over the
New ocean floor discoveries show AMOC has weakened 15% since 1950 and could slow 51% by 2100, with cascading effects on weather, monsoons
A 2025 study found that oral arginine significantly reduced amyloid plaque buildup and neuroinflammation in animal models of Alzheimer's disease.
New York City sinking at over 2mm per year threatens $18 billion in infrastructure.
